Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Gemma Fisher, Laurane Mackels, Theodora Markati, Anna Sarkozy, Julien Ochala, Heinz Jungbluth, Sithara Ramdas & Laurent Servais. (2022) Early clinical and pre-clinical therapy development in Nemaline myopathy. Expert Opinion on Therapeutic Targets 26:10, pages 853-867.
Read now
Read now
Susana Pinto & Mamede De carvalho. (2021) Phrenic nerve study as outcome in clinical trials for amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:sup1, pages 9-13.
Read now
Read now
R Hergesheimer, D Lanznaster, P Vourc’h, Cr Andres, Se Bakkouche, S Beltran, H Blasco, P Corcia & P Couratier. (2020) Advances in disease-modifying pharmacotherapies for the treatment of amyotrophic lateral sclerosis. Expert Opinion on Pharmacotherapy 21:9, pages 1103-1110.
Read now
Read now
Articles from other publishers (17)
Priscila Sales de Campos, Wendy L Olsen, James P Wymer & Barbara K Smith. (2023) Respiratory therapies for Amyotrophic Lateral Sclerosis: A state of the art review. Chronic Respiratory Disease 20, pages 147997312311759.
Crossref
Crossref
Christina N. Fournier. (2022) Considerations for Amyotrophic Lateral Sclerosis (ALS) Clinical Trial Design. Neurotherapeutics 19:4, pages 1180-1192.
Crossref
Crossref
Belgin Sever, Halilibrahim Ciftci, Hasan DeMirci, Hilal Sever, Firdevs Ocak, Burak Yulug, Hiroshi Tateishi, Takahisa Tateishi, Masami Otsuka, Mikako Fujita & Ayşe Nazlı Başak. (2022) Comprehensive Research on Past and Future Therapeutic Strategies Devoted to Treatment of Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences 23:5, pages 2400.
Crossref
Crossref
Nancy Tarantino, Ileana Canfora, Giulia Maria Camerino & Sabata Pierno. (2022) Therapeutic Targets in Amyotrophic Lateral Sclerosis: Focus on Ion Channels and Skeletal Muscle. Cells 11:3, pages 415.
Crossref
Crossref
Alessia Argirò, Mattia Zampieri, Martina Berteotti, Alberto Marchi, Luigi Tassetti, Chiara Zocchi, Luisa Iannone, Beatrice Bacchi, Francesco Cappelli, Pierluigi Stefàno, Niccolò Marchionni & Iacopo Olivotto. (2021) Emerging Medical Treatment for Hypertrophic Cardiomyopathy. Journal of Clinical Medicine 10:5, pages 951.
Crossref
Crossref
Marisa Cappella, Pierre-François Pradat, Giorgia Querin & Maria Grazia Biferi. (2021) Beyond the Traditional Clinical Trials for Amyotrophic Lateral Sclerosis and The Future Impact of Gene Therapy. Journal of Neuromuscular Diseases 8:1, pages 25-38.
Crossref
Crossref
Danielle Beaulieu, Albert A. Taylor, Dustin Pierce, Jonavelle Cuerdo, Mark Schactman, Mike Keymer & David L. Ennist. 2021. Neurotherapeutics in the Era of Translational Medicine. Neurotherapeutics in the Era of Translational Medicine
333
366
.
Khulud Alsulami & Steven Marston. (2020) Small Molecules Acting on Myofilaments as Treatments for Heart and Skeletal Muscle Diseases. International Journal of Molecular Sciences 21:24, pages 9599.
Crossref
Crossref
Rajka Maria Liscic, Antonella Alberici, Nigel John Cairns, Maurizio Romano & Emanuele Buratti. (2020) From basic research to the clinic: innovative therapies for ALS and FTD in the pipeline. Molecular Neurodegeneration 15:1.
Crossref
Crossref
Namita A. Goyal, James D. Berry, Anthony Windebank, Nathan P. Staff, Nicholas J. Maragakis, Leonard H. van den Berg, Angela Genge, Robert Miller, Robert H. Baloh, Ralph Kern, Yael Gothelf, Chaim Lebovits & Merit Cudkowicz. (2020) Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS. Muscle & Nerve 62:2, pages 156-166.
Crossref
Crossref
Zoltán Papp, Piergiuseppe Agostoni, Julian Alvarez, Dominique Bettex, Stefan Bouchez, Dulce Brito, Vladimir Černý, Josep Comin-Colet, Marisa G. Crespo-Leiro, Juan F. Delgado, István Édes, Alexander A. Eremenko, Dimitrios Farmakis, Francesco Fedele, Cândida Fonseca, Sonja Fruhwald, Massimo Girardis, Fabio Guarracino, Veli-Pekka Harjola, Matthias Heringlake, Antoine Herpain, Leo M. A. Heunks, Tryggve Husebye, Višnja Ivancan, Kristjan Karason, Sundeep Kaul, Matti Kivikko, Janek Kubica, Josep Masip, Simon Matskeplishvili, Alexandre Mebazaa, Markku S. Nieminen, Fabrizio Oliva, Julius G. Papp, John Parissis, Alexander Parkhomenko, Pentti Põder, Gerhard Pölzl, Alexander Reinecke, Sven-Erik Ricksten, Hynek Riha, Alain Rudiger, Toni Sarapohja, Robert H. G. Schwinger, Wolfgang Toller, Luigi Tritapepe, Carsten Tschöpe, Gerhard Wikström, Dirk von Lewinski, Bojan Vrtovec & Piero Pollesello. (2020) Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use. Journal of Cardiovascular Pharmacology 76:1, pages 4-22.
Crossref
Crossref
Anne-Kathrin Lutz, Stefanie Pfaender, Berra IncearapValentin IoannidisIlaria Ottonelli, Karl J. FöhrJudith CammererMarvin Zoller, Julia HigelinFederica Giona, Maximilian Stetter, Nicole Stoecker, Najwa Ouali Alami, Michael SchönMichael OrthStefan Liebau, Gotthold BarbiAndreas M. Grabrucker, Richard DelormeMichael FaulerBenjamin Mayer, Sarah JesseFrancesco Roselli, Albert C. LudolphThomas Bourgeron, Chiara Verpelli, Maria Demestre & Tobias M. Boeckers. (2020) Autism-associated SHANK3 mutations impair maturation of neuromuscular junctions and striated muscles. Science Translational Medicine 12:547.
Crossref
Crossref
Raul Juntas-Morales, Nicolas Pageot, Abdelkarim Bendarraz, Sébastien Alphandéry, Frédéric Sedel, Stéphanie Seigle & William Camu. (2020) High-dose pharmaceutical grade biotin (MD1003) in amyotrophic lateral sclerosis: A pilot study. EClinicalMedicine 19, pages 100254.
Crossref
Crossref
Ammar Al-ChalabiLeo M. A. HeunksZoltán Papp & Piero Pollesello. (2019) Potential of the Cardiovascular Drug Levosimendan in the Management of Amyotrophic Lateral Sclerosis: An Overview of a Working Hypothesis. Journal of Cardiovascular Pharmacology 74:5, pages 389-399.
Crossref
Crossref
Eun-Jeong Lee, Justin Kolb, Darren T. Hwee, Fady I. Malik & Henk L. Granzier. (2019) Functional Characterization of the Intact Diaphragm in a Nebulin-Based Nemaline Myopathy (NM) Model-Effects of the Fast Skeletal Muscle Troponin Activator tirasemtiv. International Journal of Molecular Sciences 20:20, pages 5008.
Crossref
Crossref
Raquel Guimarães-Costa, Thomas Similowski, Isabelle Rivals, Capucine Morélot-Panzini, Marie-Cécile Nierat, Mai Thao Bui, David Akbar, Christian Straus, Norma Beatriz Romero, Patrick Pierre Michel, Fabrice Menegaux, François Salachas, Jésus Gonzalez-Bermejo & Gaëlle Bruneteau. (2019) Human diaphragm atrophy in amyotrophic lateral sclerosis is not predicted by routine respiratory measures. European Respiratory Journal 53:2, pages 1801749.
Crossref
Crossref
Narendra N Jha, Jeong-Ki Kim & Umrao R Monani. (2018) Motor neuron biology and disease: a current perspective on infantile-onset spinal muscular atrophy. Future Neurology 13:3, pages 161-172.
Crossref
Crossref